Shared and distinct neurocognitive endophenotypes of schizophrenia and psychotic bipolar disorder

Clinical Psychopharmacology and Neuroscience

Volumn 13, Issue 1, 2015, Pages 94-102

  Kim, Dohoon ^a   Kim, Jiwoo ^a   Koo, Taehoon ^a   Yun, Hyerim ^a   Won, Seunghee ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Bipolar disorder; Cognition; Endophenotypes; Schizophrenia

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; BIOLOGICAL MARKER; CHOLINERGIC RECEPTOR BLOCKING AGENT; LITHIUM;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; COGNITION; COGNITION ASSESSMENT; COGNITIVE DEFECT; DISEASE SEVERITY; ENDOPHENOTYPE; FEMALE; FINGER TAPPING TEST; FIRST DEGREE RELATIVE; HUMAN; LEARNING; MALE; MANAGER; MEMORY; PSYCHOSIS; SCHIZOPHRENIA; VERBAL MEMORY; VISUAL MEMORY; WISCONSIN CARD SORTING TEST; WORKING MEMORY;

EID: 84929458185     PISSN: 17381088     EISSN: 20934327     Source Type: Journal    
DOI: 10.9758/cpn.2015.13.1.94     Document Type: Article

References (51)

1. Keshavan MS, Morris DW, Sweeney JA, Pearlson G, Thaker G, Seidman LJ, et al. A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale. Schizophr Res 2011;133:250-254.
2. Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, McIntosh AM. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry 2009;195:194-201.
3. De Peri L, Crescini A, Deste G, Fusar-Poli P, Sacchetti E, Vita A. Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies. Curr Pharm Des 2012;18:486-494.
4. Williams HJ, Norton N, Dwyer S, Moskvina V, Nikolov I, Carroll L, et al. Fine mapping of ZNF804A and genomewide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry 2011;16: 429-441.
5. Lee KW, Woon PS, Teo YY, Sim K. Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt? Neurosci Biobehav Rev 2012;36:556-571.
6. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003;160:636-645.
7. Ivleva EI, Morris DW, Moates AF, Suppes T, Thaker GK, Tamminga CA. Genetics and intermediate phenotypes of the schizophrenia - bipolar disorder boundary. Neurosci Biobehav Rev 2010;34:897-921.
8. Hill SK, Harris MS, Herbener ES, Pavuluri M, Sweeney JA. Neurocognitive allied phenotypes for schizophrenia and bipolar disorder. Schizophr Bull 2008;34:743-759.
9. Vöhringer PA, Barroilhet SA, Amerio A, Reale ML, Alvear K, Vergne D, et al. Cognitive impairment in bipolar disorder and schizophrenia: a systematic review. Front Psychiatry 2013;4:87.
10. Sitskoorn MM, Aleman A, Ebisch SJ, Appels MC, Kahn RS. Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophr Res 2004;71:285-295.
11. Snitz BE, Macdonald AW 3rd, Carter CS. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull 2006;32:179-194.
12. Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med 2008;38:771-785.
13. Balanzá-Martínez V, Rubio C, Selva-Vera G, Martinez-Aran A, Sánchez-Moreno J, Salazar-Fraile J, et al. Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review. Neurosci Biobehav Rev 2008;32:1426-1438.
14. Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 2009;113:1-20.
15. Glahn DC, Almasy L, Barguil M, Hare E, Peralta JM, Kent JW Jr, et al. Neurocognitive endophenotypes for bipolar disorder identified in multiplex multigenerational families. Arch Gen Psychiatry 2010;67:168-177.
16. Kéri S, Kelemen O, Benedek G, Janka Z. Different trait markers for schizophrenia and bipolar disorder: a neurocognitive approach. Psychol Med 2001;31:915-922.
17. Szöke A, Schürhoff F, Golmard JL, Alter C, Roy I, Méary A, et al. Familial resemblance for executive functions in families of schizophrenic and bipolar patients. Psychiatry Res 2006;144:131-138.
18. Jabben N, Arts B, van Os J, Krabbendam L. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder. J Clin Psychiatry 2010;71:764-774.
19. Ivleva EI, Morris DW, Osuji J, Moates AF, Carmody TJ, Thaker GK, et al. Cognitive endophenotypes of psychosis within dimension and diagnosis. Psychiatry Res 2012;196: 38-44.
20. Hill SK, Reilly JL, Keefe RS, Gold JM, Bishop JR, Gershon ES, et al. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry 2013;170:1275-1284.
21. th ed. Washington, D.C.: American Psychiatric Association;1994.
22. Hahn OS, Ahn JH, Song SH, Cho MJ, Kim JK, Bae JN, et al. Development of Korean version of structured clinical interview schedule for DSM-IV axis I disorder: interrater reliability. J Korean Neuropsychiatr Assoc 2000;39:362-372.
23. Ahn YM, Lee KY, Yi JS, Kang MH, Kim DH, Kim JL, et al. A validation study of the Korean-version of the Montgomery-Asberg depression rating scale. J Korean Neuropsychiatr Assoc 2005;44:466-476.
24. Jung HY, Cho HS, Joo YH, Shin HK, Yi JS, Hwang S, et al. A validation study of the Korean-version of the Young Mania Rating Scale. J Korean Neuropsychiatr Assoc 2003;42:263-269.
25. Chung YC, Cho GH, Park TW. Treatment response, remission and recovery in schizophrenia: Definition and criteria. Korean J Psychopharmacol 2006;17:5-12.
26. Silverstein A. Factor structure of the Wechsler Adult Intelligence Scale-Revised. J Consult Clin Psychol 1982;50: 661-664.
27. Yeom T, Park Y, Oh K, Lee Y. Korean version Wechsler adult intelligence scale. Seoul:Korean Guidance 4;1992. p.13-28.
28. Nuechterlein KH, Asarnow RF. Degraded Stimulus Continuous Performance Test (DS-CPT) Program for IBM-Compatible Microcomputers, Version 8.12. Los Angeles, CA:Nuechterlein and Asarnow;1999.
29. Kim H. A manual of Kims frontal-executive neuropsychological test. Daegu:Neuropsychology Press;2001.
30. Kang Y. Na D. Seoul neuropsychological screening battery (SNSB) manual. Seoul:Human Brain Research & Consulting Co;2003.
31. Heaton RK. Wisconsin card sorting test: computer version 2. Odessa:Psychological Assessment Resources;1993.
32. Morrison MW, Gregory RJ, Paul JJ. Reliability of the Finger Tapping Test and a note on sex differences. Percept Mot Skills 1979;48:139-142.
33. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998;12:426-445.
34. Szöke A, Trandafir A, Dupont ME, Méary A, Schürhoff F, Leboyer M. Longitudinal studies of cognition in schizophrenia: meta-analysis. Br J Psychiatry 2008;192:248-257.
35. Glahn DC, Bearden CE, Cakir S, Barrett JA, Najt P, Serap Monkul E, et al. Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis. Bipolar Disord 2006;8:117-123.
36. Glahn DC, Bearden CE, Barguil M, Barrett J, Reichenberg A, Bowden CL, et al. The neurocognitive signature of psychotic bipolar disorder. Biol Psychiatry 2007;62:910-916.
37. Martinez-Aran A, Torrent C, Tabares-Seisdedos R, Salamero M, Daban C, Balanza-Martinez V, et al. Neurocognitive impairment in bipolar patients with and without history of psychosis. J Clin Psychiatry 2008;69:233-239.
38. Kumar CT, Christodoulou T, Vyas NS, Kyriakopoulos M, Corrigall R, Reichenberg A, et al. Deficits in visual sustained attention differentiate genetic liability and disease expression for schizophrenia from Bipolar Disorder. Schizophr Res 2010;124:152-160.
39. Baddeley A. Working memory. Science 1992;255:556-559.
40. Park S, Püschel J, Sauter BH, Rentsch M, Hell D. Spatial working memory deficits and clinical symptoms in schizophrenia: a 4-month follow-up study. Biol Psychiatry 1999;46:392-400.
41. Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 2001;58:24-32.
42. Tuulio-Henriksson A, Haukka J, Partonen T, Varilo T, Paunio T, Ekelund J, et al. Heritability and number of quantitative trait loci of neurocognitive functions in families with schizophrenia. Am J Med Genet 2002;114:483-490.
43. Bourne C, Aydemir Ö, Balanzá-Martínez V, Bora E, Brissos S, Cavanagh JT, et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand 2013;128:149-162.
44. Curtis CE. Prefrontal and parietal contributions to spatial working memory. Neuroscience 2006;139:173-180.
45. Koch K, Wagner G, Nenadic I, Schachtzabel C, Schultz C, Roebel M, et al. Fronto-striatal hypoactivation during correct information retrieval in patients with schizophrenia: an fMRI study. Neuroscience 2008;153:54-62.
46. Meda SA, Bhattarai M, Morris NA, Astur RS, Calhoun VD, Mathalon DH, et al. An fMRI study of working memory in first-degree unaffected relatives of schizophrenia patients. Schizophr Res 2008;104:85-95.
47. Townsend J, Bookheimer SY, Foland-Ross LC, Sugar CA, Altshuler LL. fMRI abnormalities in dorsolateral prefrontal cortex during a working memory task in manic, euthymic and depressed bipolar subjects. Psychiatry Res 2010;182: 22-29.
48. Thermenos HW, Goldstein JM, Milanovic SM, Whitfield-Gabrieli S, Makris N, Laviolette P, et al. An fMRI study of working memory in persons with bipolar disorder or at genetic risk for bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2010;153B:120-131.
49. Barch DM, Sheffield JM. Cognitive impairments in psychotic disorders: common mechanisms and measurement. World Psychiatry 2014;13:224-232.
50. Barker MJ, Greenwood KM, Jackson M, Crowe SF. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol 2004;19:437-454.
51. Husa AP, Rannikko I, Moilanen J, Haapea M, Murray GK, Barnett J, et al. Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia - An observational 9-year follow-up study. Schizophr Res 2014;158:134-141.